Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura

"nAbstract "nIntroduction: Acute Idiopathic Thrombocytopenic purpura (ITP) is an autoimmune bleeding disorder of childhood caused by production of auto antibodies against platelets. The aim of the present study was to compare the efficacy of intravenous immunoglobulin (IVIG) and in...

Full description

Bibliographic Details
Main Authors: Zahra Farahmandinia, Ali Naderi, Fatemeh Sabzevari, Saeedeh Parvaresh
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2010-10-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/18828.pdf&manuscript_id=18828
_version_ 1797719595998511104
author Zahra Farahmandinia
Ali Naderi
Fatemeh Sabzevari
Saeedeh Parvaresh
author_facet Zahra Farahmandinia
Ali Naderi
Fatemeh Sabzevari
Saeedeh Parvaresh
author_sort Zahra Farahmandinia
collection DOAJ
description "nAbstract "nIntroduction: Acute Idiopathic Thrombocytopenic purpura (ITP) is an autoimmune bleeding disorder of childhood caused by production of auto antibodies against platelets. The aim of the present study was to compare the efficacy of intravenous immunoglobulin (IVIG) and intravenous anti-D(IV anti-D) in ITP treatment. "nMethods and materials: In a clinical trial, 43 children with acute ITP referred to Afzalipour Hospital, Kerman/ Iran during 2 years were studied. Children were randomly divided into two treatment groups of IVIG (n=27) and anti-D (n=16). Two groups were compared in regard to the time takes for platelets to increase, platelets count in the 10th post-treatment day and any drug side effects. "nResults: Positive response to the treatment was observed in 70.4% (19 patients) of IVIG group and 68% (11 ones) of IV anti-D group. Mean response time was 2.9 days in anti-D and 2.8 days in IVIG groups (p=0.934). Platelets count on the 10th post-treatment day in anti-D and IVIG groups were respectively 202545/μl and 204857/μl (p=0.974). Four patients in IVIG group showed side effects, while the patients in anti-D group had no complication or acute hemoglobin decrease. "nConclusion: In spite of no significant difference between IVIG and anti-D treatment groups in regard to the therapeutic outcomes, IV anti-D is suggested as the first-line treatment in acute ITP because of its lower price, more convenient administration and no need for hospitalization.
first_indexed 2024-03-12T09:07:18Z
format Article
id doaj.art-cfbd5c79f5ab440184cf76307196d94c
institution Directory Open Access Journal
issn 2008-3009
2008-2207
language English
last_indexed 2024-03-12T09:07:18Z
publishDate 2010-10-01
publisher Tehran University of Medical Sciences
record_format Article
series International Journal of Hematology-Oncology and Stem Cell Research
spelling doaj.art-cfbd5c79f5ab440184cf76307196d94c2023-09-02T15:14:29ZengTehran University of Medical SciencesInternational Journal of Hematology-Oncology and Stem Cell Research2008-30092008-22072010-10-01441013Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic PurpuraZahra FarahmandiniaAli NaderiFatemeh SabzevariSaeedeh Parvaresh"nAbstract "nIntroduction: Acute Idiopathic Thrombocytopenic purpura (ITP) is an autoimmune bleeding disorder of childhood caused by production of auto antibodies against platelets. The aim of the present study was to compare the efficacy of intravenous immunoglobulin (IVIG) and intravenous anti-D(IV anti-D) in ITP treatment. "nMethods and materials: In a clinical trial, 43 children with acute ITP referred to Afzalipour Hospital, Kerman/ Iran during 2 years were studied. Children were randomly divided into two treatment groups of IVIG (n=27) and anti-D (n=16). Two groups were compared in regard to the time takes for platelets to increase, platelets count in the 10th post-treatment day and any drug side effects. "nResults: Positive response to the treatment was observed in 70.4% (19 patients) of IVIG group and 68% (11 ones) of IV anti-D group. Mean response time was 2.9 days in anti-D and 2.8 days in IVIG groups (p=0.934). Platelets count on the 10th post-treatment day in anti-D and IVIG groups were respectively 202545/μl and 204857/μl (p=0.974). Four patients in IVIG group showed side effects, while the patients in anti-D group had no complication or acute hemoglobin decrease. "nConclusion: In spite of no significant difference between IVIG and anti-D treatment groups in regard to the therapeutic outcomes, IV anti-D is suggested as the first-line treatment in acute ITP because of its lower price, more convenient administration and no need for hospitalization.http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/18828.pdf&manuscript_id=18828 Acute idiopathic thrombocytopenic purpura (ITP)Intravenous anti-D (IV anti-D)Intravenous immunoglobulin (IVIG)
spellingShingle Zahra Farahmandinia
Ali Naderi
Fatemeh Sabzevari
Saeedeh Parvaresh
Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
International Journal of Hematology-Oncology and Stem Cell Research
Acute idiopathic thrombocytopenic purpura (ITP)
Intravenous anti-D (IV anti-D)
Intravenous immunoglobulin (IVIG)
title Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
title_full Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
title_fullStr Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
title_full_unstemmed Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
title_short Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
title_sort comparison of intravenous immunoglobulin ivig and intravenous anti d for treatment of acute idiopathic thrombocytopenic purpura
topic Acute idiopathic thrombocytopenic purpura (ITP)
Intravenous anti-D (IV anti-D)
Intravenous immunoglobulin (IVIG)
url http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/18828.pdf&manuscript_id=18828
work_keys_str_mv AT zahrafarahmandinia comparisonofintravenousimmunoglobulinivigandintravenousantidfortreatmentofacuteidiopathicthrombocytopenicpurpura
AT alinaderi comparisonofintravenousimmunoglobulinivigandintravenousantidfortreatmentofacuteidiopathicthrombocytopenicpurpura
AT fatemehsabzevari comparisonofintravenousimmunoglobulinivigandintravenousantidfortreatmentofacuteidiopathicthrombocytopenicpurpura
AT saeedehparvaresh comparisonofintravenousimmunoglobulinivigandintravenousantidfortreatmentofacuteidiopathicthrombocytopenicpurpura